More recently, it has been shown that the phenomenon is not VV specific and is mediated by increased levels of VEGF that suppress antiviral IFN response through the VEGF-A/VEGFR2/Erk/Stat3 signaling axis in tumor endothelium, rendering the cells susceptible to a range of OVs.11 The gene discussed is VEGFA; the disease is neoplasm.